Top Markets
#1 Status Status +18.91%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.51%
#3 GoPlus Security GoPlus Security +18.45%
#4 Wrapped NXM Wrapped NXM +15.13%
#5 Ontology Gas Ontology Gas +11.65%
#6 DMT-NAT DMT-NAT +8.98%
#7 Pons Pons +8.13%
#8 Provenance Blockchain Provenance Blockchain +7.18%
#9 Nesa Nesa +7.18%
#10 Janction Janction +7.01%
Coin of the day
Status Status
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Pure Biologics Spólka Akcyjna Pure Biologics Spólka Akcyjna

Pure Biologics Spólka Akcyjna

PUR
Clasificación en acciones #33926
Pure Biologics Spólka Akcyjna operates as a biopharmaceutical enterprise,... Pure Biologics Spólka Akcyjna operates as a biopharmaceutical enterprise, concentrating its efforts on the discovery and development of novel biological pharmaceuticals and targeted, non-systemic treatments. The company's key therapeutic interests span immuno-oncology, various autoimmune conditions, and rare diseases. Its capabilities encompass the entire process for antibodies and aptamers, from their initial creation and purification to detailed analysis and characterization. Additionally, Pure Biologics is skilled in the design, development, and rigorous validation of diagnostic and research assays, while also advancing technology platforms for the precise selection of active therapeutic molecules. A significant offering is PureApta, a adaptable platform engineered for the in vitro selection of modified aptamers, suitable for both medical treatment and diagnostic applications. The firm is also actively pursuing the development of localized therapies aimed at assisting individuals afflicted by neurological autoimmune disorders, including conditions like neuromyelitis optica and myasthenia gravis. Founded in 2010, Pure Biologics Spólka Akcyjna is headquartered in Wroclaw, Poland.
Precio por acción
$0.8248572
Última sincronización: 2026-08-07
Capitalización bursátil
$6.60M
Cambio (1 día)
35.02%
Cambio (1 año)
-54.35%
País
PL
Comercio Pure Biologics Spólka Akcyjna (PUR)

Categoría

Healthcare
Historial del precio de la acción de Pure Biologics Spólka Akcyjna (PUR)
Precio más alto de cierre: $0.82 el 2026-08-01

Precio más bajo de cierre: $5.33 el 2018-12-01
Historial del precio de la acción de Pure Biologics Spólka Akcyjna desde 2018 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -7.99%
2025 -72.53%
2024 74.30%
2023 -66.50%
2022 -63.85%
2021 -36.41%
2020 261.40%
2019 54.51%
2018 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE